Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tania F. Bahamondez-Canas has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antibacterial properties of Buddleja globosa: a review of extracts and bioactive compounds

    by Carolina V. Delgado-Gazzoni, Pamela A. Pérez-Basáez, Maria V. Bruna, Henry E. Garrido-Vera, Caroline R. Weinstein-Oppenheimer, Tania F. Bahamondez-Canas

    Buddleja globosa (Buddlejaceae) is a South American medicinal plant traditionally used for wound healing and other inflammatory conditions. In recent years, increasing attention has been given to its antibacterial potential and to the bioactive compounds that may contribute to this activity. This review summarizes the available evidence on the antibacterial-related activity of B. globosa extracts and selected metabolites reported in the species, including direct antibacterial effects, antibiofilm activity, antivirulence mechanisms, host-protective effects, and antibiotic-adjuvant properties. The available evidence indicates that polar extracts of B. globosa , particularly aqueous, hydroalcoholic, and ethanolic preparations, can inhibit clinically relevant bacteria such as Staphylococcus aureus, Escherichia coli , and Pseudomonas aeruginosa , although reported activity varies according to extract type, plant material, and assay methodology. Among the identified metabolites, phenylethanoid glycosides, especially verbascoside and forsythoside B, are the most relevant compounds due to their abundance in B. globosa extracts and their reported antibacterial-related mechanisms. Verbascoside shows variable direct antibacterial activity but stronger evidence as an antibiofilm, antivirulence, antitoxin, and host-protective compound. Forsythoside B displays direct activity against selected Gram-negative pathogens and potentiates conventional antibiotics against multidrug-resistant bacteria. Flavonoids such as luteolin, apigenin, quercetin, and their glycosides also contribute relevant antibacterial, antibiofilm, or antivirulence evidence, although many studies have used commercial standards or compounds isolated from other plant species. Overall, B. globosa represents a promising source of antibacterial-related bioactive compounds, but future studies should prioritize standardized extract characterization, quantitative susceptibility testing, cytotoxicity assessment, mechanistic validation, and in vivo models that connect phytochemical composition with antibacterial efficacy.


  • Plume Geometry Matters: Investigating the Contribution of Mass-Based Plume Geometry to Aerosol Delivery Efficiency in pMDIs

    by Daniel Moraga-Espinoza, Eli Eshaghian, Tania F. Bahamondez-Canas, Hugh D. C. Smyth

    To improve the performance of pressurized metered dose inhalers (pMDIs) a better mechanistic understanding of early deposition within the device and upper airways is needed to move toward more efficient inhalation therapies. The present work aimed to address the longstanding gap between plume geometry (PG) measurements and pulmonary drug delivery by evaluating PG with the Plume Induction Port Evaluator (PIPE), a mass-based method that characterizes plume angles under flow and within a restricted geometry. Three Rhodamine B solution pMDI formulations containing 2.49, 9.99, and 19.99% ethanol were evaluated at 5, 25, and 37 °C. PG was characterized by high-speed laser imaging (HSLI, 0 L/min) and by PIPE connected to a Next Generation Impactor (NGI, 30 L/min). Formulation vapor pressure, droplet size by laser diffraction, aerodynamic particle size by cascade impaction, early deposition, fine particle fraction (FPF), and respirable fraction (RF) were also determined. Deposition patterns within PIPE were log-normally distributed and consistently downward oriented, allowing calculation of mass median plume angle (MMPA) under flow. HSLI and MMPA showed opposite responses to formulation vapor pressure, where higher vapor pressure produced narrower optical PG but wider mass-based plume angles. A multivariable model incorporating MMPA, volume median diameter, formulation vapor pressure, and the MMPA × pressure interaction predicted RF with strong agreement (R2 = 0.919). These results show that early deposition in pMDIs is not governed by particle size alone, but also by plume trajectory under inhalation flow.

  • Open Access

    Buddleja globosa Extract-Enriched Gelatin–Chitosan–Hyaluronic Acid Scaffold Biocomposite Exhibits Enhanced Angiogenesis and Dermal Tissue Organization in a Chronic Wound Model

    by Ricardo A. Ceriani F, Miguel A. Fuentes-Chandia, Tania F. Bahamondez-Cañas, Donald D. Brown, Paulina A. Puebla, Enzo E. Seguel, Leticia A. Toledo, Rodrigo A. Segura-Del-Rio, Carlos F. Henríquez-Roldán, Caroline R. Weinstein-Oppenheimer

    Background: Chronic wounds represent a significant clinical challenge due to impaired healing and persistent inflammation. Bioactive scaffolds made from natural polymers combined with the hydroalcoholic extract of Buddleja globosa have emerged as promising alternatives for promoting effective tissue regeneration. Methods: A biocomposite scaffold composed of gelatin, chitosan, and hyaluronic acid, incorporating B. globosa extract, was fabricated. The material was evaluated for its physicochemical properties, biocompatibility with human neonatal dermal fibroblasts, and regenerative capacity in a chronic ischemic wound model in aged rats. Results: The composite exhibited a uniform, porous structure with an average pore size of approximately 200 μm and a high swelling capacity (>3000%) while preserving viscoelasticity with slight mechanical softening, thereby supporting optimal conditions for cell infiltration and exudate retention. The scaffold supported fibroblasts’ adhesion and proliferation, showing good biocompatibility. Formulations containing 0.04 and 0.08 mg/mL B. globosa extract significantly increased fibroblast viability at 14 days. Additionally, fibroblasts cultured on the biocomposite showed elevated secretion of proangiogenic vascular endothelial growth factor (VEGF) and CXC motif chemokine ligand 12 (CXCL12), compared to fibroblast monolayer cultures. In vivo, histological analysis revealed enhanced vascularization and reduced epithelial hyperplasia in wounds treated with the biocomposite, suggesting better tissue organization and maturation. Conclusion: Incorporating B. globosa extract into a gelatin–chitosan–hyaluronic acid scaffold offers bioactive properties that support angiogenesis and skin tissue regeneration. These results highlight the biocomposite’s potential as a multifunctional biomaterial with translational relevance for chronic wound therapy.


  • Open Access

    Optimization of Buddleja globosa-Loaded Polymeric Scaffolds for the Treatment of Biofilm-Infected Wounds

    by Tania F. Bahamondez-Canas, Ivan García-Collao, Pamela Perez-Basaez, Carolina V. Delgado-Gazzoni, Henry E. Garrido-Vera, Ricardo Ceriani, Caroline R. Weinstein-Oppenheimer, Daniel F. Moraga-Espinoza

    Chronic wounds are frequently complicated by biofilm-associated infections that impair healing and limit treatment efficacy. Buddleja globosa (BG) exhibits antimicrobial and regenerative properties, making it a promising candidate for advanced wound care. This study aimed to optimize the concentration of a standardized BG extract incorporated into polymeric scaffolds for the treatment of wounds infected with the dual-species biofilm (DSB) of Pseudomonas aeruginosa and Staphylococcus aureus. Scaffolds containing increasing BG concentrations (BG1 to BG4) were fabricated by lyophilization and characterized in terms of physicochemical properties, antimicrobial activity, and cytocompatibility. Their therapeutic efficacy was further evaluated using an in vitro artificial wound model and a murine model of a DSB-infected wound. BG incorporation significantly influenced the scaffold properties. While BG1–BG3 maintained a comparable structure and mechanical integrity, BG4 exhibited a reduced pore size, swelling capacity, and mechanical resistance. All BG-loaded scaffolds reduced bacterial viability in vitro, with BG4 showing the strongest antimicrobial effect. In vivo, BG2 showed the most consistent overall performance, combining improved wound closure at day 6 with complete re-epithelialization at the endpoint. BG3 improved wound closure at day 6 but did not outperform it in re-epithelialization. In contrast, BG4 did not enhance healing despite its higher antimicrobial activity in vitro. These findings demonstrate that scaffold performance is governed by the interplay between extract loading and physicochemical properties, and that intermediate BG concentrations provide more favorable conditions for tissue repair than higher loadings. This work supports the potential of BG-loaded scaffolds as a therapeutic strategy for biofilm-infected chronic wounds.


  • Open Access

    Potencial antibacteriano y antifúngico de las especies Haplopappus en Chile

    by Henry Garrido-Vera, Carolina Delgado-Gazzoni, Waleska Vera-Quezada, Tania F Bahamondez-Cañas

    Introducción: Los extractos de plantas han sido usados tradicionalmente para tratar diferentes afecciones y el género Haplopappus destaca entre aquellos a los que se le han atribuido propiedades antimicrobianas. Las infusiones de Haplopappus sp. se usan para tratar el dolor abdominal, enfermedades del tracto urinario y para limpiar heridas. Considerando que la prevención de infecciones es un aspecto crítico del cuidado de heridas y de la necesidad urgente de nuevos agentes antimicrobianos, esta revisión tiene como objetivo analizar las propiedades antimicrobianas de extractos de plantas del género de Haplopappus en Chile. Material y método: Doce artículos fueron seleccionados en esta revisión y describen el análisis de las propiedades antibacterianas y antifúngicas de quince especies de Haplopappus estudiadas como diferentes tipos de extractos, tales como infusiones y exudados. Resultados: Los extractos fueron estudiados en 30 especies bacterianas, destacando sus propiedades inhibitorias contra bacterias gram positivo como Staphylococcus aureus. Las actividades más potentes fueron contra Bacillus cereus y Bacillus subtilis para el exudado resinoso de H. litoralis y H. chrysanthemifolius. El efecto de los extractos contra especies fúngicas también fue estudiado, pero en menor medida, con actividad inhibitoria descrita contra Acremonium falciforme y Fusarium oxysporum. Conclusión: El efecto antimicrobiano de los extractos de especies de Haplopappus requiere estudios más estandarizados que fortalezcan la evidencia actual y permitan explorar actividades antiinfecciosas, así como evaluar de manera específica la acción inhibitoria de compuestos aislados, en particular los clerodanos.


  • Open Access

    Gelatin-Based Microspheres of Ciprofloxacin for Enhanced Lung Delivery and Biofilm Eradication in Pseudomonas aeruginosa Pulmonary Infections

    by Luis Monrreal-Ortega, Rocío Iturriaga-Gallardo, Andrea Vilicic-Rubio, Pedro Torres, Patricio Leyton, Javier O. Morales, Tania F. Bahamondez-Canas, Daniel Moraga-Espinoza

    Chronic lung infection is the main predictor of morbidity and mortality in cystic fibrosis (CF), and current pharmacological alternatives are ineffective against Pseudomonas aeruginosa infections. We developed ciprofloxacin (CIP) for inhalation, aiming at improving its solubility through the formation of an amorphous solid dispersion (ASD) using gelatin (GA). CIP and GA were dissolved in varying ratios and then spray-dried, obtaining CIP-GA microspheres in a single step. The dissolution rate, size distribution, morphology, and aerodynamic properties of CIP-GA microspheres were studied, as well as their antimicrobial activity on P. aeruginosa biofilms. Microspheres formulated with a higher GA ratio increased the dissolution of CIP ten-fold at 6 h compared to gelatin-free CIP. Formulations with 75% GA or more could form ASDs and improve CIP’s dissolution rate. CIP-GA microspheres outperformed CIP in eradicating P. aeruginosa biofilm at 24 h. The spray-drying process produced CIP-GA microspheres with good aerodynamic properties, as indicated by a fine particle fraction (FPF) of 67%, a D50 of 3.52 μm, and encapsulation efficiencies above 70%. Overall, this study demonstrates the potential of gelatin to enhance the solubility of poorly soluble drugs by forming ASDs. As an FDA-approved excipient for lung delivery, these findings are valuable for particle engineering and facilitating the rapid translation of technologies to the market.


  • Open Access

    Tailoring Polymeric Scaffolds with Buddleja globosa Extract for Dual Antimicrobial and Biocompatible Wound Healing Applications

    by Ricardo Ceriani, Daniel A. Cherif-Pino, Pamela Pérez-Basáez, Marcela Escobar, Patricio Leyton, Caroline R. Weinstein-Oppenheimer, Daniel F. Moraga-Espinoza, Tania F. Bahamondez-Canas

    Integrating traditional herbal extracts into modern biomaterials offers a promising route for advanced wound care. A standardized Buddleja globosa Hope extract (BG-126), recognized for its therapeutic value, was incorporated into polymeric scaffolds with variable composition to explore their potential in promoting wound healing and controlling infections. This work aimed to identify the polymeric composition of a scaffold with BG-126 that maximizes its compatibility and antimicrobial properties. Scaffolds were developed by lyophilization using a Box–Behnken design (BBD) with chitosan, hyaluronic acid, and gelatin content as study factors. Thirteen scaffold formulations were tested for their antimicrobial activity against Staphylococcus aureus and Pseudomonas aeruginosa, including biofilm forms, as well as for their biocompatibility with normal human fibroblasts. Structural and physical properties, such as the moisture content and swelling capacity, were evaluated. The best-performing scaffold was analyzed using Raman spectroscopy. The chitosan content was strongly associated with antimicrobial efficacy, while gelatin enhanced fibroblast compatibility (R2 ≥ 0.9). No correlations were identified between the polymeric content and biofilm inhibition or physical properties. BG-126-loaded scaffolds reduced planktonic and biofilm proliferation and improved fibroblast compatibility compared to the control scaffold (without BG-126). The results support the rational design of botanical-loaded scaffolds with targeted properties for wound healing.


  • Open Access

    Isolation, Chemical Characterization, and Antimicrobial Activity of Secondary Metabolites from Pseudocyphellaria faveolata

    by Cecilia Rubio, Javiera Ramírez, Caroline Weinstein-Oppenheimer, Tania F. Bahamondez-Canas, Natalia Quiñones

    Introduction: Antimicrobial resistance is a global threat, highlighting the urgent need for novel antimicrobial agents. Among the mechanisms of resistance, bacteria can release drug-degrading enzymes and express efflux pumps, as well as grow in protected aggregates known as biofilms. Pseudomonas aeruginosa and Staphylococcus aureus are among the most prevalent biofilm infections in chronic wounds, respiratory and urinary tract infections, and device-associated infections. Pseudocyphellaria faveolata (Delise) Malme is a lichen with metabolites with unexplored antimicrobial potential. Aims: To identify and characterize the major metabolites present in Pseudocyphellaria Faveolata and to determine their antimicrobial activity against Staphylococcus aureus and Pseudomonas aeruginosa. Methods: The molecules were purified by column chromatography and characterized by NMR spectroscopy. The antimicrobial activity of the compounds was determined in terms of proliferation, adhesion, and viability against P. aeruginosa and S. aureus by the broth microdilution method and crystal violet staining. Viability was determined by the resazurin reduction assay on normal human fibroblasts to determine cytotoxicity over human cells. Results: The major metabolites were spectroscopically characterized and identified as physciosporin and methyl virensate. Physciosporin showed antimicrobial activity on S. aureus, with a MIC of 32 μg/mL and MBC of 128 μg/mL, and prevented biofilm formation from 16 μg/mL. Methyl virensate also had antimicrobial activity on S. aureus (MIC = 64 μg/mL). None of these metabolites significantly affected P. aeruginosa proliferation, viability, or adhesion. Cytotoxicity of physciosporin at 16 ug/mL on normal human fibroblasts was below 20%. Conclusions: This is the first report on the study of the antimicrobial activity of these compounds. Physciosporin showed promising activity in preventing the formation of S. aureus biofilms, which are responsible for chronic infections. These findings provide a foundation for exploring the antimicrobial potential of other lichenic depsidones.


  • Essential Pharmaceutics

    by Ashlee D. Brunaugh, Daniel Moraga-Espinoza, Tania F. Bahamondez-Canas, Hugh D. C. Smyth, Robert O. Williams


  • The forgotten material: Highly dispersible and swellable gelatin-based microspheres for pulmonary drug delivery of cromolyn sodium and ipratropium bromide

    by Beatriz Behrend-Keim, Almendra Castro-Muñoz, Luis Monrreal-Ortega, Bárbara Ávalos-León, Carolina Campos-Estrada, Hugh D.C. Smyth, Tania F. Bahamondez-Canas, Daniel Moraga-Espinoza